(Total Views: 444)
Posted On: 09/20/2025 11:00:41 AM
Post# of 157275

Re: Boatbuilder #157099
Emmitt was actually speaking about milestones that have not occurred yet, instead of those that resulted in a .30 share price.
But since you asked, the company has created a defensible MOA that shows the great likelihood of Leron creating an environment where any checkpoint inhibitor can become miles better than any other.
And the milestones to come will be -- most importantly, showing that MOA prospectively instead of retrospectively through raising PD-L1 in the CRC trial. Any benefit that results besides this in the CRC trial will be a help. Showing any progress at all against glioblastoma (pre-clinical) is a milestone to come. Showing any progress at all against Alzheimer's in the privately funded study is a milestone to come. Dr. Sacha initiating the Latch trial is a milestone. Advances in the triple-therapy cure for HIV -- like a human trial, which Sacha has said he intends to pursue -- will be a milestone. There are more, but I'm not entirely sure you are interested.
But since you asked, the company has created a defensible MOA that shows the great likelihood of Leron creating an environment where any checkpoint inhibitor can become miles better than any other.
And the milestones to come will be -- most importantly, showing that MOA prospectively instead of retrospectively through raising PD-L1 in the CRC trial. Any benefit that results besides this in the CRC trial will be a help. Showing any progress at all against glioblastoma (pre-clinical) is a milestone to come. Showing any progress at all against Alzheimer's in the privately funded study is a milestone to come. Dr. Sacha initiating the Latch trial is a milestone. Advances in the triple-therapy cure for HIV -- like a human trial, which Sacha has said he intends to pursue -- will be a milestone. There are more, but I'm not entirely sure you are interested.

